USFDA approves Lupin’s Posaconazole tablets
Lupin’s Posaconazole Delayed-release tablets launched into the market after receiving approval from the USFDA : On 17 February 2021, Lupin Limited announced the launch of Posaconazole delayed–release tablets in the United States. This tablet is marketed at the dose of 100 mg. The approval for the ANDA[1] product from the USFDA[2] was secured by the […]